IO Biotech Inc

NASDAQ IOBT

Data sourced from iex and EODHD
Download Data

IO Biotech Inc Income Statement 2019 - 2023

This table shows the Income Statement for IO Biotech Inc going from 2019 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Revenue
M 0 0 0 0 0
Cost of Revenue
M 1 1 - - -
Gross Profit
M -1 -1 - - -
Operating Expenses
M 91 71 - - -
Selling, General, and Administrative Expenses (SG&A)
M 24 24 11 2 2
Research and Development (R&D) Expenses
M 68 47 30 8 8
Other Operating Expenses
M -1 -1 - - -
Costs and Expenses
M 90 71 - - -
Operating Income
M -91 -71 -41 -10 -10
Interest Expense
M 0 0 0 0 0
Non-operating Income/Expense
M 6 1 -27 -2 -1
EBT
M -85 -70 -68 -12 -11
Income Tax Provision
M 1 1 0 0 0
Income after Tax
M -86 -71 -68 -12 -11
Non-Controlling Interest
M - 0 7 3 2
Net Income
M - -71 -75 -15 -13
Shares (Basic, Weighted)
M - - - - -
Shares (Diluted, Weighted)
R 43,539,976.00 28,815,267.00 28,815,267.00 28,815,267.00 4,834,891.00
EBITDA
M -91 -70 -68 -12 -11
Depreciation and Amortization
M 1 1 -27 -2 -1
EBIT
M -91 -71 -41 -10 -10
Income from Discontinued Operations
M - - - - -
Tax Rate (Effective)
% -1.00 -1.81 -0.10 -0.22 -0.06
Earnings Per Share (EPS), Basic
M - - - - -
Earnings Per Share (EPS), Diluted
M - 0 0 0 0
Gross Profit Margin
% - - - - -
Operating Income Margin
% - - - - -
Net Income Margin
% - - - - -
EBITDA Ratio
% - - - - -
EBIT Ratio
% - - - - -
EBT Ratio
% - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email